RT Journal Article
T1 Plasma Rich in Growth Factors (PRGF) in Transepithelial Photorefractive Keratectomy (TPRK).
A1 Sánchez-González, José-María
A1 Alonso-Aliste, Federico
A1 Borroni, Davide
A1 Amián-Cordero, Jonatan
A1 De-Hita-Cantalejo, Concepción
A1 Capote-Puente, Raúl
A1 Bautista-Llamas, María-José
A1 Sánchez-González, María Carmen
A1 Rodríguez-Calvo-de-Mora, Marina
A1 Rocha-de-Lossada, Carlos
K1 photorefractive keratectomy
K1 plasma rich in growth factor
K1 refractive outcomes
K1 transepithelial photorefractive keratectomy
K1 visual outcomes
AB To evaluate the usage of plasma rich in growth factor (PRGF) in transepithelial photorefractive keratectomy (TPRK) in low and moderate myopia, patients who underwent myopic and astigmatism TPRK with PRGF were involved in this retrospective, observational study. Subjects underwent a surgical procedure between February 2019 and June 2019. A three-month follow-up was recorded. Pain score was assessed with a visual analogue scale (0-10) and re-epithelialization time recorded. A total of 48 eyes from 24 patients were recruited. Mean uncorrected distance visual acuity (UDVA) was 20/20.31 (0.00 ± 0.02 LogMAR). A total of 98% of eyes did not change corrected distance visual acuity (CDVA) lines. Two percent of eyes lost one line of CDVA. Preoperative spherical equivalent was -2.67 ± 1.37 D and after three months changed to -0.21 ± 0.34 D, and 2% of eyes changed 0.50 D or more between one and three months. Pain score was 3.29 ± 0.61 (3 to 6) score points at day one and 0.08 ± 0.27 score points at day seven. Finally, re-epithelialization time was 2.50 ± 1.20 days. PRGF addition to conventional refractive treatment such as TPRK seems to alleviate immediate postoperative pain and positively contribute to corneal re-epithelization time.
SN 2077-0383
YR 2021
FD 2021-04-30
LK http://hdl.handle.net/10668/17745
UL http://hdl.handle.net/10668/17745
LA en
DS RISalud
RD Apr 18, 2025